Australia's most trusted
source of pharma news
Monday, 07 October 2024
Posted 1 October 2024 AM
HCPs involved in the controversial issue of prescribing for ADHD are endeavouring to address what they describe as "significant variability in ADHD prescribing across the country" with the publication of Australia's first prescribing guide for the condition.
The Australasian ADHD Professionals Association (AADPA) says its new guide "delivers clear and consistent information on the pharmacological treatment of ADHD across different age groups and settings".
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.